MedTrace Logo

WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate Cancer

NCT02858128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2016-08-09

No results posted yet for this study

Summary

The purpose of this study is to determine the effectiveness of whole-body diffusion-weighted magnetic resonance imaging (WB-DW- MRI) in detecting metastases by comparing the results with those from choline-positron emission tomography-computed tomography (choline-PET/CT) in patients with metastatic/oligometastatic prostate cancer. Patients with this disease profile who could benefit from treatment with stereotactic body radiation therapy (SBRT) were selected and their responses to these techniques were rated.

Conditions

Interventions

OTHER

IMAGING STUDY

Choline-PET/CT versus NMRscan comparative study

Sponsors & Collaborators

  • Hospital Provincial de Castellon

    lead OTHER

Principal Investigators

  • Antonio J Conde Moreno, MD PhD · Hospital Provincial de Castellon

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-03-31
Completion
2015-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02858128 on ClinicalTrials.gov